GB1254893A - Therapeutic composition - Google Patents

Therapeutic composition

Info

Publication number
GB1254893A
GB1254893A GB4113/69A GB411369A GB1254893A GB 1254893 A GB1254893 A GB 1254893A GB 4113/69 A GB4113/69 A GB 4113/69A GB 411369 A GB411369 A GB 411369A GB 1254893 A GB1254893 A GB 1254893A
Authority
GB
United Kingdom
Prior art keywords
jan
therapeutic compositions
compositions
therapeutic composition
dragúes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4113/69A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of GB1254893A publication Critical patent/GB1254893A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1,254,893. Therapeutic compositions. J. R. GEIGY A.G. 24 Jan., 1969 [26 Jan., 1968], No. 4113/69. Heading A5B. Therapeutic compositions for producing anticonvulsive muscle relaxing or CNS-depressing effects comprise a pharmaceutical carrier and a therapeutically effective amount of 3-amino- 4-phenyl furazan in dosage unit form acceptable for internal administration. The compositions may be in the form of dragÚes, tablets, suppositories, ampoules or capsules containing conventional excipients.
GB4113/69A 1968-01-26 1969-01-24 Therapeutic composition Expired GB1254893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH125068 1968-01-26

Publications (1)

Publication Number Publication Date
GB1254893A true GB1254893A (en) 1971-11-24

Family

ID=4205989

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4113/69A Expired GB1254893A (en) 1968-01-26 1969-01-24 Therapeutic composition

Country Status (7)

Country Link
US (1) US3577544A (en)
BE (1) BE727363A (en)
DE (1) DE1903569A1 (en)
FR (1) FR2000802A1 (en)
GB (1) GB1254893A (en)
IL (1) IL31486A (en)
NL (1) NL6900839A (en)

Also Published As

Publication number Publication date
US3577544A (en) 1971-05-04
NL6900839A (en) 1969-07-29
BE727363A (en) 1969-07-24
IL31486A (en) 1972-07-26
FR2000802A1 (en) 1969-09-12
DE1903569A1 (en) 1969-08-28
IL31486A0 (en) 1969-03-27

Similar Documents

Publication Publication Date Title
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
GB1310594A (en) Antidepressant compositions and dosage units
GB1204580A (en) Pharmaceutical dosage forms
NZ225242A (en) Pad printing process for manufacturing a pharmaceutical presentation and/or dosage form for active ingredients of drugs
GB1227534A (en)
GB1221393A (en) Improvements in or relating to hepato-protective drugs
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
GB1341794A (en) Medicament for the treatment of hepatic disorders
GB1254893A (en) Therapeutic composition
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB1291559A (en) N-(4-chlorocinnamoyl)-4-hydroxypiperidine
GB1254057A (en) Improvements in or relating to therapeutical composition containing vincamine
GB1352392A (en) Phenylisopropylamine derivatives
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
FR2472391B1 (en)
ES347203A1 (en) Compositions for Treating Mental Disorders
GB1242742A (en) Drug for stimulating the central nervous system
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
GB1251237A (en)
JPS5332110A (en) Pharmaceutical composition containing gamma-oryzanol
GB1429977A (en) Diuretic composition
GB1050396A (en)
IE36780B1 (en) New pharmaceutical preparations
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone